Discontinued operations (in dollars per share)
Edwards Lifesciences Discontinued operations (in dollars per share) decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from $-0.01 to $0.00. Over 3 years (FY 2022 to FY 2025), Discontinued operations (in dollars per share) shows a downward trend with a -54.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Positive values indicate that discontinued segments contributed to earnings, while negative values indicate a drag on total net income.
Detailed definition
This represents the net income or loss generated by discontinued operations on a per-share basis, adjusted for applicabl...
Peer comparison
Standard reporting requirement for any company undergoing significant restructuring or asset divestment.
eps_income_loss_from_discontinued_operations_net_of_tax__0b787cHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.08 | $0.08 | $0.08 | $0.08 | $0.07 | $0.09 | $0.08 | $0.06 | $0.04 | $0.00 | $4.52 | $0.07 | -$0.01 | -$0.01 | $0.00 | $0.05 | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -12.5% | +28.6% | -11.1% | -25.0% | -33.3% | -100.0% | — | -98.5% | -114.3% | +0.0% | +100.0% | — | -100.0% |
| YoY Change | — | — | — | — | -12.5% | +12.5% | +0.0% | -25.0% | -42.9% | -100.0% | >999% | +16.7% | -125.0% | — | -100.0% | -28.6% | +100.0% |
Discontinued operations (in dollars per share) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's discontinued operations (in dollars per share)?
- Edwards Lifesciences (EW) reported discontinued operations (in dollars per share) of $0.00 in Q1 2026.
- How has Edwards Lifesciences's discontinued operations (in dollars per share) changed year-over-year?
- Edwards Lifesciences's discontinued operations (in dollars per share) increased by 100.0% year-over-year, from $-0.01 to $0.00.
- What is the long-term trend for Edwards Lifesciences's discontinued operations (in dollars per share)?
- Over 3 years (2022 to 2025), Edwards Lifesciences's discontinued operations (in dollars per share) has grown at a -54.6% compound annual growth rate (CAGR), from $0.32 to $0.03.
- What does discontinued operations (in dollars per share) mean?
- The per-share profit or loss resulting from business segments that are no longer part of the company's core operations.